HealthEquity Return on Investment 2014-2025 | HQY
Current and historical return on investment (ROI) values for HealthEquity (HQY) over the last 10 years.
| HealthEquity ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-10-31 | $0.29B | $3.12B | 9.32% |
| 2025-07-31 | $0.24B | $3.15B | 7.40% |
| 2025-04-30 | $0.20B | $3.18B | 6.37% |
| 2025-01-31 | $0.16B | $3.17B | 5.15% |
| 2024-10-31 | $0.16B | $3.21B | 5.16% |
| 2024-07-31 | $0.17B | $3.26B | 5.67% |
| 2024-04-30 | $0.14B | $3.02B | 4.72% |
| 2024-01-31 | $0.12B | $2.91B | 4.15% |
| 2023-10-31 | $0.09B | $2.86B | 3.26% |
| 2023-07-31 | $0.07B | $2.82B | 2.39% |
| 2023-04-30 | $0.04B | $2.79B | 1.43% |
| 2023-01-31 | $0.01B | $2.80B | 0.36% |
| 2022-10-31 | $-0.03B | $2.80B | -1.08% |
| 2022-07-31 | $-0.04B | $2.78B | -1.29% |
| 2022-04-30 | $-0.04B | $2.77B | -1.26% |
| 2022-01-31 | $-0.02B | $2.78B | -0.87% |
| 2021-10-31 | $0.00B | $2.80B | 0.04% |
| 2021-07-31 | $0.01B | $2.76B | 0.51% |
| 2021-04-30 | $0.02B | $2.76B | 0.95% |
| 2021-01-31 | $0.03B | $2.30B | 1.49% |
| 2020-10-31 | $0.05B | $2.29B | 2.26% |
| 2020-07-31 | $0.05B | $2.29B | 2.20% |
| 2020-04-30 | $0.07B | $2.21B | 3.92% |
| 2020-01-31 | $0.08B | $2.21B | 7.05% |
| 2019-10-31 | $0.08B | $2.21B | 14.45% |
| 2019-07-31 | $0.09B | 0.00% | |
| 2019-04-30 | $0.09B | 0.00% | |
| 2019-01-31 | $0.08B | 0.00% | |
| 2018-10-31 | $0.07B | 0.00% | |
| 2018-07-31 | $0.07B | 0.00% | |
| 2018-04-30 | $0.06B | 0.00% | |
| 2018-01-31 | $0.05B | 0.00% | |
| 2017-10-31 | $0.05B | 0.00% | |
| 2017-07-31 | $0.05B | 0.00% | |
| 2017-04-30 | $0.04B | 0.00% | |
| 2017-01-31 | $0.04B | 0.00% | |
| 2016-10-31 | $0.04B | 0.00% | |
| 2016-07-31 | $0.04B | 0.00% | |
| 2016-04-30 | $0.03B | 0.00% | |
| 2016-01-31 | $0.03B | 0.00% | |
| 2015-10-31 | $0.02B | 0.00% | |
| 2015-07-31 | $0.02B | 0.00% | |
| 2015-04-30 | $0.02B | 0.00% | |
| 2015-01-31 | $0.02B | 0.00% | |
| 2014-07-31 | $0.01B | 0.00% | |
| 2014-04-30 | $0.01B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.224B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.818B | 31.00 |
| HCA Healthcare (HCA) | United States | $108.237B | 17.92 |
| CVS Health (CVS) | United States | $102.012B | 11.73 |
| Elevance Health (ELV) | United States | $83.333B | 12.22 |
| Cencora (COR) | United States | $66.377B | 21.40 |
| Natera (NTRA) | United States | $32.568B | 0.00 |
| DiDi Global (DIDIY) | China | $23.956B | 22.13 |
| Labcorp Holdings (LH) | United States | $20.757B | 15.83 |
| Medpace Holdings (MEDP) | United States | $16.879B | 41.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.455B | 0.00 |
| BioMerieux (BMXMF) | France | $15.505B | 0.00 |
| Solventum (SOLV) | United States | $14.863B | 14.43 |
| Viatris (VTRS) | United States | $14.604B | 5.44 |
| ICON (ICLR) | Ireland | $14.548B | 14.44 |
| Revvity (RVTY) | United States | $11.779B | 21.69 |
| CochLear (CHEOY) | Australia | $11.666B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.769B | 20.74 |
| Avantor (AVTR) | United States | $8.373B | 12.79 |
| Sonic Healthcare (SKHHY) | Australia | $7.695B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.223B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.036B | 41.95 |
| PACS (PACS) | United States | $6.501B | 39.53 |
| Bausch + Lomb (BLCO) | Canada | $6.199B | 40.70 |
| Sotera Health (SHC) | United States | $5.395B | 26.01 |
| Alignment Healthcare (ALHC) | United States | $4.258B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.447B | 60.53 |
| Concentras Parent (CON) | United States | $2.642B | 16.49 |
| Progyny (PGNY) | United States | $2.450B | 48.17 |
| Organon (OGN) | United States | $2.111B | 2.22 |
| Surgery Partners (SGRY) | United States | $2.106B | 27.13 |
| Pediatrix Medical (MD) | United States | $1.946B | 11.62 |
| Establishment Labs Holdings (ESTA) | United States | $1.940B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.287B | 0.00 |
| Nutex Health (NUTX) | United States | $1.278B | 9.77 |
| Ardent Health (ARDT) | United States | $1.269B | 4.14 |
| CareDx (CDNA) | United States | $1.058B | 17.29 |
| GoodRx Holdings (GDRX) | United States | $0.978B | 16.00 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| Embecta (EMBC) | United States | $0.761B | 4.33 |
| InnovAge Holding (INNV) | United States | $0.754B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.672B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.602B | 0.00 |
| CryoPort (CYRX) | United States | $0.533B | 0.00 |
| Enhabit (EHAB) | United States | $0.516B | 23.16 |
| Strata Critical Medical (SRTA) | United States | $0.500B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.459B | 8.43 |
| Agilon Health (AGL) | United States | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.379B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.358B | 75.29 |
| Auna S.A (AUNA) | Luxembourg | $0.355B | 5.70 |
| Shoulder Innovations (SI) | United States | $0.292B | 0.00 |
| So-Young (SY) | China | $0.278B | 0.00 |
| KindlyMD (NAKA) | United States | $0.203B | 0.00 |
| LifeMD (LFMD) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.144B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.088B | 0.00 |
| Biodesix (BDSX) | United States | $0.064B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |